Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
10
×
startups
10
×
deals
life sciences
national top stories
vc
wisconsin blog main
wisconsin top stories
biotech
san francisco blog main
wisconsin
fda
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco top stories
boston blog main
food and drug administration
healthcare
medical radioisotopes
medtech
radioisotopes
san francisco
shine medical technologies
boston top stories
deerfield management
greg piefer
ipo
isotopes
katrina pitas
m&a
medical devices
medical imaging
medical isotopes
medical technology
molybdenum-99
nuclear regulatory commission
raleigh-durham blog main
tech
What
deal
10
×
medical
shine
acquire
startup
technologies
wi
announced
based
biggest
bio
business
deerfield
janesville
latest
medicines
million
time
venture
wisconsin's
years
ability
according
acquisition
acquisitions
add
adding
aiming
ambys
appear
array
atrial
babies
big
biotech
boosts
boston
building
capital
catch
Language
unset
Current search:
" national blog main "
×
startups
×
deal
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
WI Watchlist: Epic, Shine, Venture Investors, Stratatech & More
@xconomy.com
4 years ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
@xconomy.com
5 years ago
ResMed Boosts Connected Health Play With $225M Propeller Health Deal
@xconomy.com
5 years ago
Shine Raises $30M, Could Add $150M More After Inking Deerfield Deal
@xconomy.com
5 years ago
After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
5 years ago
The Biggest Wisconsin Venture Round of the Decade… Didn’t Happen
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed